Total Payments
$26,350
2024 Payments
$15.37
Companies
5
Transactions
43
Medicare Patients
3,015
Medicare Billing
$247,427
Payment Breakdown by Category
Other$15,300 (58.1%)
Consulting$6,733 (25.6%)
Travel$3,288 (12.5%)
Food & Beverage$1,028 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,300 | 4 | 58.1% |
| Consulting Fee | $6,733 | 2 | 25.6% |
| Travel and Lodging | $3,288 | 14 | 12.5% |
| Food and Beverage | $1,028 | 23 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $25,190 | 31 | $0 (2024) |
| AstraZeneca UK Limited | $1,118 | 9 | $0 (2023) |
| Philips Electronics North America Corporation | $19.08 | 1 | $0 (2018) |
| Allergan Inc. | $11.61 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $11.56 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.37 | 1 | Insmed, Inc. ($15.37) |
| 2023 | $1,118 | 9 | AstraZeneca UK Limited ($1,118) |
| 2020 | $7,244 | 9 | Insmed, Inc. ($7,244) |
| 2019 | $17,930 | 21 | Insmed, Inc. ($17,930) |
| 2018 | $30.64 | 2 | Philips Electronics North America Corporation ($19.08) |
| 2017 | $11.61 | 1 | Allergan Inc. ($11.61) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Respiratory | ||||||
| 02/09/2023 | AstraZeneca UK Limited | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $214.52 | General |
| Category: Respiratory | ||||||
| 02/09/2023 | AstraZeneca UK Limited | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $153.33 | General |
| Category: Respiratory | ||||||
| 02/09/2023 | AstraZeneca UK Limited | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $82.71 | General |
| Category: Respiratory | ||||||
| 02/09/2023 | AstraZeneca UK Limited | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $52.83 | General |
| Category: Respiratory | ||||||
| 02/09/2023 | AstraZeneca UK Limited | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Respiratory | ||||||
| 02/08/2023 | AstraZeneca UK Limited | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $214.52 | General |
| Category: Respiratory | ||||||
| 02/08/2023 | AstraZeneca UK Limited | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $176.92 | General |
| Category: Respiratory | ||||||
| 02/08/2023 | AstraZeneca UK Limited | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $44.70 | General |
| Category: Respiratory | ||||||
| 02/06/2023 | AstraZeneca UK Limited | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $155.00 | General |
| Category: Respiratory | ||||||
| 08/26/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: Respiratory | ||||||
| 02/25/2020 | Insmed, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,475.00 | General |
| 02/25/2020 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $126.89 | General |
| 02/11/2020 | Insmed, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,825.00 | General |
| 02/11/2020 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $116.07 | General |
| 02/07/2020 | Insmed, Inc. | — | Travel and Lodging | In-kind items and services | $270.07 | General |
| 01/15/2020 | Insmed, Inc. | — | Travel and Lodging | Cash or cash equivalent | $425.10 | General |
| 01/13/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: Respiratory | ||||||
| 01/13/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $1.05 | General |
| Category: Respiratory | ||||||
| 11/22/2019 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $18.54 | General |
| 11/11/2019 | Insmed, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| 08/13/2019 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $333.33 | General |
| Category: Respiratory | ||||||
| 08/07/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Respiratory | ||||||
| 05/10/2019 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $6,400.00 | General |
| Category: Respiratory | ||||||
| 05/10/2019 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | Cash or cash equivalent | $24.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 638 | 872 | $227,763 | $60,825 |
| 2022 | 16 | 838 | 1,012 | $223,814 | $59,336 |
| 2021 | 14 | 892 | 1,127 | $257,071 | $65,297 |
| 2020 | 15 | 647 | 865 | $213,896 | $61,968 |
Total Patients
3,015
Total Services
3,876
Medicare Billing
$247,427
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 36 | 88 | $62,040 | $14,286 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 72 | 117 | $25,207 | $11,513 | 45.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 113 | $30,611 | $10,269 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 105 | 138 | $25,530 | $9,433 | 36.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 13 | 54 | $17,826 | $4,397 | 24.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $13,382 | $3,627 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $8,450 | $3,064 | 36.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 22 | $4,046 | $1,329 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 23 | $3,157 | $1,005 | 31.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 61 | 61 | $16,524 | $513.52 | 3.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 75 | 75 | $1,919 | $468.28 | 24.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 78 | 80 | $11,600 | $458.02 | 3.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 11 | 11 | $1,452 | $187.22 | 12.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 21 | 21 | $5,603 | $164.64 | 2.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 13 | 13 | $416.00 | $110.04 | 26.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 36 | 64 | $39,180 | $10,619 | 27.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 63 | 64 | $30,400 | $9,452 | 31.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 64 | 97 | $17,638 | $9,357 | 53.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 66 | 117 | $28,665 | $9,125 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 80 | 119 | $18,659 | $8,303 | 44.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 20 | 20 | $6,120 | $2,797 | 45.7% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 14 | 28 | $8,715 | $2,323 | 26.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 32 | $5,440 | $1,691 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $3,832 | $1,354 | 35.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 108 | 109 | $28,244 | $954.42 | 3.4% |
About Dr. Andreas Schmid, MD
Dr. Andreas Schmid, MD is a Internal Medicine healthcare provider based in Kansas City, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1962663377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andreas Schmid, MD has received a total of $26,350 in payments from pharmaceutical and medical device companies, with $15.37 received in 2024. These payments were reported across 43 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,300).
As a Medicare-enrolled provider, Schmid has provided services to 3,015 Medicare beneficiaries, totaling 3,876 services with total Medicare billing of $247,427. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Kansas City, KS
- Active Since 06/18/2008
- Last Updated 01/04/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962663377
Products in Payments
- Arikayce (Drug) $16,212
- BREZTRI (Drug) $1,118
- Wellcentive Undiv (Device) $19.08
- ZENPEP (Drug) $11.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kansas City
James O'keefe, Md, MD
Internal Medicine — Payments: $834,178
Internal Medicine $834,178
Shadi Hamdeh, Md, MD
Internal Medicine — Payments: $623,244
Internal Medicine $623,244
Dr. Patrick Moriarty, M.d, M.D
Internal Medicine — Payments: $618,967
Internal Medicine $618,967
Gerald Mancuso, M.d, M.D
Internal Medicine — Payments: $615,894
Internal Medicine $615,894
Dr. Ryan Taylor, M.d, M.D
Internal Medicine — Payments: $512,094
Internal Medicine $512,094
Sanjaya Gupta, Md, MD
Internal Medicine — Payments: $325,155
Internal Medicine $325,155